WO2002038161A1 - Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers - Google Patents
Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers Download PDFInfo
- Publication number
- WO2002038161A1 WO2002038161A1 PCT/US2001/046344 US0146344W WO0238161A1 WO 2002038161 A1 WO2002038161 A1 WO 2002038161A1 US 0146344 W US0146344 W US 0146344W WO 0238161 A1 WO0238161 A1 WO 0238161A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- contact lens
- preservative
- phmb
- bis
- none
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/141—Biguanides, e.g. chlorhexidine
- A61L12/142—Polymeric biguanides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/143—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/143—Quaternary ammonium compounds
- A61L12/145—Polymeric quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/22—Carbohydrates or derivatives thereof
- C11D3/221—Mono, di- or trisaccharides or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3723—Polyamines or polyalkyleneimines
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/261—Alcohols; Phenols
Definitions
- the present invention relates to the field of ophthalmic solutions and their uses.
- the invention relates to contact lens cleaning solutions, contact lens rinsing and storing solutions, solutions to deliver active pharmaceutical agents to the eye, solutions for disinfecting ophtalmic devices and the like.
- the present invention relates to the field of ophthalmic solutions and especially to the aspects of preservative efficacy and comfort after prolonged use. These ophthalmic solutions have been used for some period of time and are available as over the counter products. Solutions that are used in direct contact with corneal tissue such as the delivery of active pharmaceutical agent to the eye, or indirectly, such as the cleaning, conditioning or storage of devices that will come in contact with corneal tissue, such as contact lenses, there is a need to insure that these solution do not introduce sources of bacterial or other microbial infection. Thus preservatives are included to reduce the viability of microbes in the solution and to lessen the chance of contamination of the solution by the user since many of the solutions are bought, opened, used, sealed and then reused.
- preservative agents include polyhexamethylene biguanide (phmb), polyquad tm , chlorhexidine, and benzalkonium chloride, and the like, all of which at some concentration irritate corneal tissue and lead to user discomfort. Therefore, a solution that employs a given amount of a preservative agent, but which is made more effective by addition of an agent that is not a preservative agent would be desired.
- Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions.
- the solutions specifically described herein have 0.001 to about 1 percent of inositol in combination with other active ingredients useful in ophthalmic solutions such as buffers, preservatives, surfactants, and antimicrobial agents, and with a low chloride concentration, less than about 0.2 percent by weight. It has been found, surprisingly that inositol, and other sugars including mannitol, sorbitol, sucrose, dextrose, glycerin and propylene glycol, effectively increase the antibacterial effect of preservatives in low salt (low chloride) conditions.
- the preservatives that are specifically useful are cationic polymeric preservatives such as polyhexamethylene biguanide (phmb), polyquad tm , chlorhexidne, and benzalkonium chloride, as well as other cationic preservatives that may prove useful in the present invention as well.
- the cationic preservatives are used at effective amounts as preservatives, and in the instance of PHMB from 0.0001 percent by weight to higher levels of about 0.01 weight percent.
- the cationic polymeric preservative includes polymeric biguanides such as polymeric hexamethylene biguanides (PHMB), and combinations thereof.
- Such cationic polymeric biguanides, and water-soluble salts thereof having the following formula:
- Z is an organic divalent bridging group which may be the same or different throughout the polymer, n is on average at least 3, preferably on average 5 to 20, and X 1 and X 2 are
- water-soluble polymeric biguanides will have number average molecular weights of at least 1 ,000 and more preferably will have number average molecular weights from 1 ,000 to 50,000.
- Suitable water-soluble salts of the free bases include, but are not limited to hydrochloride, borate, acetate, gluconate, sulfonate, tartrate and citrate salts.
- polystyrene foam Most preferred are the polymeric hexamethylene biguanides, commercially available, for example, as the hydrochloride salt from Zeneca (Wilmington, Del.) under the trademark CosmocilTM CQ. Such polymers and water-soluble salts are referred to as polyhexamethylene (PHMB) or polyaminoptopyl biguanide (PAPB).
- PHMB polyhexamethylene
- PAPB polyaminoptopyl biguanide
- polyhexamethylene biguanide is meant to encompass one or more biguanides have the following formula:
- n is from 1 to 500.
- the predominant compound falling within the above formula may have different X 1 and X 2 groups or the same groups, with lesser amounts of other compounds within the formula.
- Such compounds are known and are disclosed in U.S. Pat. No. 4.758,595 and British Patent 1 ,432,345, which patents are hereby incorporated.
- the water- soluble salts are compounds where n has an average value of 2 to 15, most preferably 3 to 12.
- Inositol used in ophthalmic solutions increases preservative efficacy in certain formulations, provides increased resistance to infection in corneal tissue, in certain formulations, and improves the quality of tears in certain formulations.
- the formulations may also include buffers such as phosphates, bicarbonate, citrate, borate, ACES, BES, BICINE, BIS-Tris, BIS-Tris Propane, HEPES, HEPPS, imidazole, MES, MOPS, PIPES, TAPS, TES, and Tricine
- buffers such as phosphates, bicarbonate, citrate, borate, ACES, BES, BICINE, BIS-Tris, BIS-Tris Propane, HEPES, HEPPS, imidazole, MES, MOPS, PIPES, TAPS, TES, and Tricine
- Surfactants that might be employed include polysorbate surfactants, polyoxyethylene surfactants, phosphonates, saponins and polyethoxylated castor oils, but preerrably the polyethoxylated castor oils. These surfactants are commercially available.
- the polyethoxylated castor oils are sold by BASF under the trademark Cremaphor.
- Inositol, mannitol, sorbitol, sucrose, dextrose, glycerin, propylene glycol and the other agents used in the present invention are all commercially available, and well enough understood to be formulated into products within the scope of the invention by those skilled in the art.
- solutions of the present invention may contain other additives including but not limited to buffers, tonicity agents, demulcents, wetting agents, preservatives, sequestering agents (chelating agents), surface active agents, and enzymes.
- chelating agent preferably disodium EDTA
- additional microbicide preferably 0.00001 to 0.1 or 0.0000 1 to 0.01
- weight percent chelating agent preferably disodium EDTA
- additional microbicide preferably 0.00001 to 0.1 or 0.0000 1 to 0.01
- weight percent polyhexamethylene biquanide PHMB0, N- alkyl-2-pyrrolidone, chlorhexidine, polyquaternium- 1 , hexetidine, bronopol, alexidine, low concentrations of hydrogen peroxide, and ophthalmologically acceptable salts thereof
- Ophthalmologically acceptable chelating agents useful in the present invention include amino carboxylic acid compounds or water-soluble salts thereof, including ethylenediaminetetraacetic acid, nitrilotriacetic acid, diethylenetriamine pentaacetic acid, hydroxyethylethylenediaminetriacetic acid, 1 ,2-diaminocyclohexanetetraacetic acid, ethylene glycol bis (beta-aminoethyl ether) in N, N, N ⁇ N' tetraacetic acid (EGTA), aminodiacetic acid and hydroxyethylamino diacetic acid.
- These acids can be used in the form of their water soluble salts, particularly their alkali metal salts.
- Especially preferred chelating agents are the di-, tn- and tetra-sodium salts of ethylenediaminetetraacetic acid (EDTA), most preferably disodium EDTA (Disodium Edetate).
- citrates and polyphosphates can also be used in the present invention.
- the citrates which can be used in the present invention include citric acid and its mono-, di-, and tri-alkaline metal salts.
- the polyphosphates which can be used include pyrophosphates, triphosphates, tetraphosphates, trimetaphosphates, tetrametaphosphates, as well as more highly condensed phosphates in the form of the neutral or acidic alkali metal salts such as the sodium and potassium salts as well as the ammonium salt.
- the pH of the solutions should be adjusted to be compatible with the eye and the contact lens, such as between 6.0 to 8.0, preferably between 6.8 to 7.8 or between 7.0 to 7.6. Significant deviations from neutral (pH 7.3) will cause changes in the physical parameters (i.e. diameter) in some contact lenses. Low pH (pH less than 5.5) can cause burning and stinging of the eyes, while very low or very high pH (less than 3.0 or greater than 10) can cause ocular damage.
- the additional preservatives employed in the present invention are known, such as polyhexamethylene biguanide, N-alkyl-2-pyrrolidone, chlorhexidine, polyhexamethylenebiguanide, alexidine, polyquaternium- 1 , hexetidine, bronopol and a very low concentration of hydrogen peroxide, e.g., 30 to 200 ppm.
- the solutions of the invention are compatible with both rigid gas permeable and hydrophilic contact lenses during storage, cleaning, wetting, soaking, rinsing and disinfection.
- a typical aqueous solution of the present invention may contain additional ingredients which would not affect the basic and novel characteristics of the active ingredients described earlier, such as tonicity agents, surfactants and viscosity inducing agents, which may aid in either the lens cleaning or in providing lubrication to the eye.
- Suitable tonicity agents include sodium chloride, potassium chloride, glycerol or mixtures thereof
- the tonicity of the solution is typically adjusted to approximately 240-310 milliosmoles per kilogram solution (mOsm/kg) to render the solution compatible with ocular tissue and with hydrophilic contact lenses.
- the solution contains 0.01 to 0.2 weight percent sodium chloride. The important factor is to keep the concentrations of such additives to a degree no greater than that would supply a chloride concentration of no greater than about 0.2 mole percent.
- Suitable viscosity inducing agents can include lecithin or the cellulose derivatives such as hydroxymethylcellulose, hydroxypropylcellulose and methylcellulose in amounts similar to those for surfactants, above.
- Formulations containing inositol were prepared in a 0.2% phosphate buffer.
- the solutions were made isotonic with sodium chloride and preserved with polyhexamethylene biquanide at 0.0001%.
- the pH was adjusted to 7.2 with either 1 N sodium hydroxide or 1 N hydrochloric acid.
- the in vitro microbicidal activity of the solutions was determined by exposing C. albicans to 10 ml of each solution at room temperature for 4 hours. Subsequently, an aliquot of each solution was serial diluted onto agar plates and incubated for 48 hours at elevated temperatures. At the conclusion of the incubation period the plates are examined for the development of colonies. The log reduction was determined based on a comparison to the inoculum control. The following table provides the results of the in vitro studies.
- the solution containing inositol showed an improvement in the activity against C. albicans as compared to the buffer control.
- a formulation was prepared by dissolving Tricine, Allantoin, Inositol, Disodium edetate, and Polyoxyl 40 Hydrogenated Castor Oil in 80% of the water volume.
- the pH of the solution was adjusted to 7.3 with 1 N sodium hydroxide.
- the tonicity of the solution was adjusted with sodium chloride and polyhexamethylene biguanide was added.
- the solution was diluted to volume with water.
- Example 3B Sugar/Glycol Preservative Efficacy Relationship to Salt Concentration
- Example 3B Sugar/Glycol Preservative Efficacy Relationship to Salt Concentration
- Example 3C Solutions with less than 0.1% chloride specifically using glycerin
- PHMB cationic polymeric preservative
- Example 3E The Lens Conditioning Properties of Saccharide Containing Formulations
- Solutions were formulated with sodium chloride, sorbitol and sucrose and then lenses were immersed in the resultant solutions and chlorohexidine gluconate was added. The lenses were exposed for 3 hours and the amount of the chlorohexidine deposited on the lens was measured.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Eyeglasses (AREA)
- Cosmetics (AREA)
- Toxicology (AREA)
Abstract
Description
Claims
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2428985A CA2428985C (en) | 2000-11-08 | 2001-11-08 | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
DE60140007T DE60140007D1 (en) | 2000-11-08 | 2001-11-08 | IMPROVED OPHTHALMIC AND CONTACT LENS SOLUTIONS WITH SIMPLE SACCHARIDES AS A PRESERVATION IMPROVERS |
AT01993467T ATE443749T1 (en) | 2000-11-08 | 2001-11-08 | IMPROVED OPHTHALMIC AND CONTACT LENS SOLUTIONS WITH SIMPLE SACCHARIDES AS PRESERVATION IMPROVEMENTS |
US10/544,151 US9492581B2 (en) | 2000-11-08 | 2001-11-08 | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
AU2002227206A AU2002227206B2 (en) | 2000-11-08 | 2001-11-08 | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
DK01993467T DK1339418T3 (en) | 2000-11-08 | 2001-11-08 | Enhanced ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
AU2720602A AU2720602A (en) | 2000-11-08 | 2001-11-08 | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US10/544,151 US20060142169A1 (en) | 2000-11-08 | 2001-11-08 | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
EP01993467A EP1339418B1 (en) | 2000-11-08 | 2001-11-08 | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
JP2002540744A JP4084997B2 (en) | 2000-11-08 | 2001-11-08 | Improved ophthalmic and contact lens solutions containing simple sugars as preservative enhancers |
AU2006207883A AU2006207883B2 (en) | 2000-11-08 | 2006-09-07 | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US11/613,029 US9492582B2 (en) | 2000-11-08 | 2006-12-19 | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US15/278,660 US9913474B2 (en) | 2000-11-08 | 2016-09-28 | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US15/881,203 US10244760B2 (en) | 2000-11-08 | 2018-01-26 | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US16/272,579 US10531663B2 (en) | 2000-11-08 | 2019-02-11 | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24687000P | 2000-11-08 | 2000-11-08 | |
US60/246,870 | 2000-11-08 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/544,151 A-371-Of-International US9492581B2 (en) | 2000-11-08 | 2001-11-08 | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US11/613,029 Continuation-In-Part US9492582B2 (en) | 2000-11-08 | 2006-12-19 | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002038161A1 true WO2002038161A1 (en) | 2002-05-16 |
Family
ID=22932591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/046344 WO2002038161A1 (en) | 2000-11-08 | 2001-11-08 | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
Country Status (13)
Country | Link |
---|---|
US (2) | US20060142169A1 (en) |
EP (1) | EP1339418B1 (en) |
JP (1) | JP4084997B2 (en) |
CN (1) | CN1245166C (en) |
AT (1) | ATE443749T1 (en) |
AU (3) | AU2720602A (en) |
CA (1) | CA2428985C (en) |
CY (1) | CY1111043T1 (en) |
DE (1) | DE60140007D1 (en) |
DK (1) | DK1339418T3 (en) |
ES (1) | ES2330617T3 (en) |
PT (1) | PT1339418E (en) |
WO (1) | WO2002038161A1 (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002043482A2 (en) * | 2000-11-29 | 2002-06-06 | Novartis Ag | Aqueous disinfecting systems |
WO2005060953A1 (en) * | 2003-12-09 | 2005-07-07 | Alcon, Inc. | Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions |
WO2005089772A2 (en) * | 2004-03-12 | 2005-09-29 | Bausch & Lomb Incorporated | Prevention of loss of tight cell junctions using carbohydrate-containing compositions |
EP1642568A1 (en) * | 2004-08-03 | 2006-04-05 | Prontomed GmbH | Mouthwash |
WO2006055454A2 (en) * | 2004-11-16 | 2006-05-26 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
WO2007027898A2 (en) * | 2005-08-31 | 2007-03-08 | Kimberly-Clark Worldwide, Inc. | Antimicrobial composition |
WO2008077110A2 (en) * | 2006-12-19 | 2008-06-26 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
WO2008086270A2 (en) * | 2007-01-05 | 2008-07-17 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing forms of vitamin b |
US7550418B2 (en) | 2002-12-13 | 2009-06-23 | Novartis Ag | Lens care composition and method |
US7858000B2 (en) | 2006-06-08 | 2010-12-28 | Novartis Ag | Method of making silicone hydrogel contact lenses |
US8647658B2 (en) | 2007-08-31 | 2014-02-11 | Novartis Ag | Contact lens products |
US8689971B2 (en) | 2007-08-31 | 2014-04-08 | Novartis Ag | Contact lens packaging solutions |
US8957048B2 (en) | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
US9308264B2 (en) | 2000-11-08 | 2016-04-12 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
US9314528B2 (en) | 2011-12-07 | 2016-04-19 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
US9829723B2 (en) | 2015-12-03 | 2017-11-28 | Novartis Ag | Contact lens packaging solutions |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
US9913474B2 (en) | 2000-11-08 | 2018-03-13 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
WO2018109456A1 (en) * | 2016-12-12 | 2018-06-21 | Provita Eurotech Ltd | Antimicrobial compositions |
US10279005B2 (en) | 2014-11-25 | 2019-05-07 | Allergan, Inc. | Stabilized omega-3 ophthalmic compositions |
US10632202B2 (en) | 2016-03-04 | 2020-04-28 | Johnson & Johnson Consumer Inc. | Preservative containing compositions |
US11033625B2 (en) | 2005-10-06 | 2021-06-15 | Allergan, Inc. | Method for stabilizing a toxin |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030129083A1 (en) * | 1997-11-26 | 2003-07-10 | Advanced Medical Optics, Inc. | Multi purpose contact lens care compositions including propylene glycol or glycerin |
JP4565500B2 (en) * | 2005-01-18 | 2010-10-20 | 株式会社シード | Contact lens solution |
JP5135526B2 (en) * | 2005-06-27 | 2013-02-06 | 株式会社メニコンネクト | Contact lens solution |
MX2009000316A (en) * | 2006-07-12 | 2009-01-26 | Novartis Ag | Actinically crosslinkable copolymers for manufacturing contact lenses. |
JP5033380B2 (en) * | 2006-08-30 | 2012-09-26 | ディバーシー株式会社 | Disinfectant composition and disinfectant cleaning composition for tableware, cooking utensils, food processing plant or kitchen, and sterilization method or disinfecting cleaning method for tableware, cooking utensils, food processing plant or kitchen facilities using the same |
AR064286A1 (en) | 2006-12-13 | 2009-03-25 | Quiceno Gomez Alexandra Lorena | PRODUCTION OF OPHTHALMIC DEVICES BASED ON POLYMERIZATION BY PHOTOINDUCIDED SCALE GROWTH |
CN101310070B (en) * | 2007-02-06 | 2010-09-22 | 三菱电机株式会社 | Deodorizing method and device for garment or the like |
WO2009113161A1 (en) | 2008-03-12 | 2009-09-17 | 株式会社メニコン | Solution composition for contact lenses |
CN102190591A (en) * | 2010-03-12 | 2011-09-21 | 陈郁 | Metal complex, preparation method and application thereof |
EP2612664A4 (en) * | 2010-09-02 | 2014-03-19 | Menicon Co Ltd | Stabilized polyphenol solution and method for stabilizing polyphenol solution |
MX345216B (en) * | 2011-06-23 | 2017-01-18 | Santen Pharmaceutical Co Ltd | Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6139646A (en) * | 1998-09-01 | 2000-10-31 | Alcon Laboratories, Inc. | Alkyl trypsin compositions and methods of use in contact lens cleaning and disinfecting systems |
Family Cites Families (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1432345A (en) * | 1920-09-15 | 1922-10-17 | Powers Accounting Machine Comp | Rotary selector or analyzer |
US2976576A (en) * | 1956-04-24 | 1961-03-28 | Wichterle Otto | Process for producing shaped articles from three-dimensional hydrophilic high polymers |
US3429576A (en) | 1965-08-28 | 1969-02-25 | Yoshiaki Ikeda | Golf club having level indicating means and weight means |
GB1152243A (en) | 1965-11-26 | 1969-05-14 | Ici Ltd | Process for the Manufacture of Polymeric Diguanides |
US3503393A (en) * | 1966-05-19 | 1970-03-31 | Blease Anaesthetic Equip Ltd | Patient controlled respiratory apparatus |
DE1667942B2 (en) | 1967-03-15 | 1977-05-12 | Ceskoslovenska Akademie Ved, Prag | METHOD AND DEVICE FOR STERILE STORAGE OF OBJECTS FROM SWELLED HYDOGELS, IN PARTICULAR OF CONTACT LENSES |
US3689673A (en) * | 1970-11-10 | 1972-09-05 | Barnes Hind Pharm Inc | The process of soaking and sterilizing hydrophilic soft contact lenses with chlorhexidene |
US3755561A (en) * | 1971-03-22 | 1973-08-28 | Burton Parsons & Co Inc | Bactericidal contact lens solution |
FR2199470B1 (en) | 1971-06-21 | 1977-12-30 | Wave Energy Systems | |
US3873696A (en) | 1972-01-31 | 1975-03-25 | Allergan Pharma | Cleaning and sterilizing soft contact lens |
NO135634C (en) | 1972-03-16 | 1977-05-04 | Farmaceutisk Ind As | |
US4022834A (en) * | 1972-03-16 | 1977-05-10 | A/S Farmaceutisk Industri | Antibacterially active hexamethylene-bis-biguanides |
US3888782A (en) | 1972-05-08 | 1975-06-10 | Allergan Pharma | Soft contact lens preserving solution |
US3876768A (en) | 1972-11-06 | 1975-04-08 | Hydrophilics Int Inc | Sterilization of soft, hydrophilic acrylate and methacrylate copolymer materials |
US3911107A (en) | 1972-12-18 | 1975-10-07 | Flow Pharma Inc | Iodine composition and dissipating solution |
US3910296A (en) | 1973-04-20 | 1975-10-07 | Allergan Pharma | Method of removing proteinaceous deposits from contact lenses |
US3943251A (en) | 1973-06-27 | 1976-03-09 | Medow Norman B | Ophthamological use of hydrastis compounds |
US4029817A (en) | 1973-09-24 | 1977-06-14 | Allergan Pharmaceuticals | Soft contact lens preserving solutions |
GB1562899A (en) * | 1975-06-17 | 1980-03-19 | Wellcome Found | Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof |
US4046706A (en) | 1976-04-06 | 1977-09-06 | Flow Pharmaceuticals, Inc. | Contact lens cleaning composition |
IT1063325B (en) | 1976-05-19 | 1985-02-11 | Brevitex Ets Exploit | DEVICE FOR SPREADING THE CROSSBODY FRAMES |
US4136173A (en) | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
US4209817A (en) | 1978-03-15 | 1980-06-24 | Square D Company | Circuit breaker having an electronic fault sensing and trip initiating unit |
US4394381A (en) | 1979-04-13 | 1983-07-19 | George F. And Irene Sherrill 1978 Trust No. 1 | Method for the relief of pain |
US4361549A (en) | 1979-04-26 | 1982-11-30 | Ortho Pharmaceutical Corporation | Complement-fixing monoclonal antibody to human T cells, and methods of preparing same |
JPS599600B2 (en) * | 1980-11-14 | 1984-03-03 | 花王株式会社 | Shampoo - Composition |
US4361548A (en) * | 1980-11-28 | 1982-11-30 | Bausch & Lomb Incorporated | Contact lens disinfecting and preserving solution (polymeric) |
US4361458A (en) | 1981-02-13 | 1982-11-30 | The Wurlitzer Company | Piano soundboard and method of making same |
US4354952A (en) | 1981-03-12 | 1982-10-19 | Bausch & Lomb Incorporated | Contact lens disinfecting and preserving solution comprising chlorhexidine and salts thereof |
JPS5810517A (en) | 1981-07-13 | 1983-01-21 | Santen Pharmaceut Co Ltd | Ophthalmic solution containing non-steroid antiphlogistic agent as main component |
US4525346A (en) | 1981-09-28 | 1985-06-25 | Alcon Laboratories, Inc. | Aqueous antimicrobial ophthalmic solutions |
US4820352A (en) * | 1983-01-10 | 1989-04-11 | Bausch & Lomb Incorporated | Cleaning and conditioning solutions for contact lenses and methods of use |
JPS6038323A (en) | 1983-08-10 | 1985-02-27 | Sankyo Co Ltd | Ophthalmic anti-inflammatory agent |
US4758595A (en) | 1984-12-11 | 1988-07-19 | Bausch & Lomb Incorporated | Disinfecting and preserving systems and methods of use |
US4836986A (en) * | 1984-09-28 | 1989-06-06 | Bausch & Lomb Incorporated | Disinfecting and preserving systems and methods of use |
US4748189A (en) | 1985-04-19 | 1988-05-31 | Ciba-Geigy Corporation | Ophthalmic solutions and methods for improving the comfort and safety of contact lenses |
USRE32672E (en) | 1985-09-09 | 1988-05-24 | Allergan, Inc. | Method for simultaneously cleaning and disinfecting contact lenses using a mixture of peroxide and proteolytic enzyme |
JPH0696521B2 (en) * | 1986-01-31 | 1994-11-30 | 千寿製薬株式会社 | Ocular hypotensive agent for topical ocular administration |
JPH0672866B2 (en) * | 1986-03-19 | 1994-09-14 | 本田技研工業株式会社 | Oxygen concentration detector |
JPH01104006A (en) | 1986-08-07 | 1989-04-21 | Medice Chem Pharm Fab Puetter Gmbh & Co Kg | Medicine |
US4863900A (en) | 1987-01-15 | 1989-09-05 | The Research Foundation Of State University Of New York | Method for reducing viral transmission with poly-L-histidine |
US4783488A (en) | 1987-01-31 | 1988-11-08 | Bausch & Lomb Incorporated | Contact lens wetting solution |
US5246708A (en) * | 1987-10-28 | 1993-09-21 | Pro-Neuron, Inc. | Methods for promoting wound healing with deoxyribonucleosides |
US5624958A (en) | 1987-12-31 | 1997-04-29 | Isaacs; Charles E. | Disinfecting contact lenses |
US5192535A (en) | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
JPH01211595A (en) | 1988-02-18 | 1989-08-24 | Kikkoman Corp | Novel n-acetyl-beta-d-glucosamine derivative, production thereof and utilization thereof to reagent for measuring n-acetyl-beta-d-glucosamidase activity |
US5607698A (en) * | 1988-08-04 | 1997-03-04 | Ciba-Geigy Corporation | Method of preserving ophthalmic solution and compositions therefor |
US5089261A (en) | 1989-01-23 | 1992-02-18 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
US4891423A (en) | 1989-03-20 | 1990-01-02 | Stockel Richard F | Polymeric biguanides |
US5182258A (en) | 1989-03-20 | 1993-01-26 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
US5175161A (en) * | 1989-04-06 | 1992-12-29 | Sankyo Company, Limited | Occular hypotensive agents |
JP2893537B2 (en) | 1989-07-20 | 1999-05-24 | 東海電化工業株式会社 | Histidine-hydrogen peroxide adduct and method for producing the same |
BR9007573A (en) | 1989-08-01 | 1992-06-30 | Schering Corp | CONTACT LENS DISINFECTION SYSTEM |
US4988710A (en) * | 1989-08-25 | 1991-01-29 | Washington University | Aryl-cycloalkyl-alkanolamines for treatment of cholinergic neurotoxins |
US4997626A (en) * | 1990-01-05 | 1991-03-05 | Allergan, Inc. | Methods to disinfect contact lenses |
US5279673A (en) * | 1990-01-05 | 1994-01-18 | Allergan, Inc. | Methods to disinfect contact lenses |
US5078908A (en) * | 1989-10-02 | 1992-01-07 | Allergan, Inc. | Methods for generating chlorine dioxide and compositions for disinfecting |
US5300296A (en) * | 1989-11-06 | 1994-04-05 | Frank J. Holly | Antimicrobial agent for opthalmic formulations |
GB9002422D0 (en) | 1990-02-03 | 1990-04-04 | Boots Co Plc | Anti-microbial compositions |
US5174872A (en) | 1990-06-08 | 1992-12-29 | Technicon Instruments Corporation | Metal-free buffer for ion selective electrode-based assays |
US5102670A (en) | 1990-09-14 | 1992-04-07 | Abraham Nader G | Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels |
WO1992011042A1 (en) | 1990-12-19 | 1992-07-09 | Allergan, Inc. | Compositions and methods for contact lens disinfecting |
SG49774A1 (en) | 1990-12-27 | 1998-06-15 | Allergan Inc | Method and composition for disinfection contact lenses |
NZ242358A (en) | 1991-05-10 | 1994-03-25 | Allergan Inc | Use of thiol compounds to inhibit deposits on a contact lens |
US5439572A (en) | 1991-12-02 | 1995-08-08 | Isoclear, Inc. | Lens protective encasement packet |
US5387394A (en) | 1992-06-29 | 1995-02-07 | Allergan, Inc. | Ophthalmic compositions and methods for preserving and using same |
AU6363694A (en) * | 1993-03-18 | 1994-10-11 | Polymer Technology Corporation | Alcohol-containing abrasive composition for cleaning contact lenses |
DE4345199C2 (en) | 1993-05-22 | 1995-10-12 | Asta Medica Ag | Use of dihydrolipoic acid to suppress intolerance reactions in the border area of implants with living body tissue |
WO1994027440A1 (en) * | 1993-05-26 | 1994-12-08 | Fresenius Ag | Anti-infective agents |
US5968904A (en) | 1993-06-04 | 1999-10-19 | Demegen, Inc. | Modified arginine containing lytic peptides and method of making the same by glyoxylation |
US5561107A (en) * | 1993-06-04 | 1996-10-01 | Demeter Biotechnologies, Ltd. | Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides |
IL109762A0 (en) | 1993-06-18 | 1994-08-26 | Allergan Inc | Method for treating hypoxia-associated ocular complications |
US5661130A (en) * | 1993-06-24 | 1997-08-26 | The Uab Research Foundation | Absorption enhancers for drug administration |
US5449658A (en) | 1993-12-07 | 1995-09-12 | Zeneca, Inc. | Biocidal compositions comprising polyhexamethylene biguanide and EDTA, and methods for treating commercial and recreational water |
US5591773A (en) | 1994-03-14 | 1997-01-07 | The Trustees Of Columbia University In The City Of New York | Inhibition of cataract formation, diseases resulting from oxidative stress, and HIV replication by caffeic acid esters |
US5361287A (en) | 1994-03-29 | 1994-11-01 | B&W Fuel Company | Nuclear fuel assembly lower end fitting |
WO1995026734A1 (en) * | 1994-04-04 | 1995-10-12 | Freeman William R | Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure |
US5674450A (en) * | 1994-04-28 | 1997-10-07 | Johnson & Johnson Medical, Inc. | Vapor sterilization using a non-aqueous source of hydrogen peroxide |
US5547990A (en) | 1994-05-20 | 1996-08-20 | Lonza, Inc. | Disinfectants and sanitizers with reduced eye irritation potential |
US5494937A (en) | 1994-07-22 | 1996-02-27 | Alcon Laboratories, Inc. | Saline solution for treating contact lenses |
AU3070395A (en) | 1994-07-22 | 1996-02-22 | Alcon Laboratories, Inc. | Use of low molecular weight amino acids in ophthalmic compositions |
AU3155195A (en) | 1994-08-26 | 1996-03-22 | Alcon Laboratories, Inc. | Polyalkylene oxide containing quaternary ammonium antimicrobial agents |
EP1089078B1 (en) * | 1994-10-20 | 2007-02-28 | Sysmex Corporation | Reagent and method for analyzing solid components in urine |
US5739178A (en) * | 1995-05-15 | 1998-04-14 | Allergan | Polymer, article and method for inhibiting the growth of ocular pathogens in eye care products |
US5718895A (en) | 1995-11-16 | 1998-02-17 | Alcon Laboratories, Inc. | Enzymes with low isoelectric points for use in contact lens cleaning |
US5780450A (en) | 1995-11-21 | 1998-07-14 | Alcon Laboratories, Inc. | Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage |
US5965736A (en) * | 1996-01-16 | 1999-10-12 | Lumigen, Inc. | Compositions and methods for generating red chemiluminescence |
US5925317A (en) | 1996-01-22 | 1999-07-20 | Bausch & Lomb Incorporated | Dual neutralization system for iodine treatment of contact lenses |
AU720405B2 (en) | 1996-02-16 | 2000-06-01 | Regents Of The University Of California, The | Antimicrobial peptides and methods of use |
AU2079497A (en) | 1996-03-18 | 1997-10-10 | Bio-Lab, Inc. | Water clarifying compositions |
DE69737828T2 (en) | 1996-04-29 | 2008-03-06 | Novozymes A/S | LIQUID, NON-AQUEOUS ENZYMES CONTAINING COMPOSITIONS |
JPH1059846A (en) | 1996-06-10 | 1998-03-03 | Kikkoman Corp | Preventive or remedy for cararacta |
US5719110A (en) | 1996-08-14 | 1998-02-17 | Allergan | Contact lens care compositions with inositol phosphate components |
JP3698832B2 (en) | 1996-10-08 | 2005-09-21 | 株式会社メニコン | Contact lens solution |
US5958984A (en) | 1996-10-10 | 1999-09-28 | Devillez; Richard L. | Method and composition for skin treatment |
JP3829380B2 (en) * | 1996-12-18 | 2006-10-04 | 住友化学株式会社 | Pest repellent and pest repellent method |
US5945446A (en) | 1997-02-10 | 1999-08-31 | Laubc Biochemicals, Corporation | Process for preparing synthetic soil-extract materials and medicaments based thereon |
US6022732A (en) | 1997-04-09 | 2000-02-08 | Allergan | Hydrogen peroxide destroying compositions and methods of using same |
RU2127100C1 (en) | 1997-04-17 | 1999-03-10 | Борзенок Сергей Анатольевич | Ocular drops "pyrotonik" |
US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
US5925320A (en) | 1997-06-04 | 1999-07-20 | Jones; John P. | Air purification system |
WO1999023887A1 (en) | 1997-11-10 | 1999-05-20 | Novo Nordisk A/S | Antimicrobial activity of laccases |
JPH11137649A (en) | 1997-11-10 | 1999-05-25 | Tomey Technology Kk | Method for cleaning and disinfecting contact lens |
EP1030692B1 (en) | 1997-11-12 | 2002-07-10 | Bausch & Lomb Incorporated | Treatment of contact lenses with aqueous solution comprising an alkali carbonate |
EP1030903A1 (en) | 1997-11-12 | 2000-08-30 | Bausch & Lomb Incorporated | Disinfecting contact lenses with polyquaterniums and polymeric biguanides |
US6056920A (en) | 1997-12-12 | 2000-05-02 | Vertex Pharmaceuticals Incorporated | Process for identifying a solvent condition suitable for determining a biophysical property of a protein |
JPH11249087A (en) | 1997-12-18 | 1999-09-17 | Tome:Kk | Light agent for contact lens |
JP3883739B2 (en) | 1998-05-22 | 2007-02-21 | 株式会社メニコン | Contact lens bactericidal solution |
JP2000016965A (en) | 1998-06-29 | 2000-01-18 | Mitsubishi Gas Chem Co Inc | Production of hydroxyalkylacrylic ester or methacrylic acid ester modified with caprolactone |
US6117869A (en) | 1998-08-04 | 2000-09-12 | Warner-Lambert Company | Compounds for and methods of inhibiting matrix metalloproteinases |
US6162393A (en) * | 1998-08-06 | 2000-12-19 | Ndt, Inc. | Contact lens and ophthalmic solutions |
CA2309039A1 (en) | 1998-08-21 | 2000-03-02 | Hiroshi Aki | Agent for contact lenses |
US6309596B1 (en) | 1998-12-15 | 2001-10-30 | Bausch & Lomb Incorporated | Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by a poloxamine |
US7678836B2 (en) | 1999-11-04 | 2010-03-16 | Fxs Ventures, Llc | Method for rendering a contact lens wettable |
US6153563A (en) | 1999-11-10 | 2000-11-28 | Lithchem International | Pouched ingredients for preparing greases |
US8557868B2 (en) * | 2000-11-04 | 2013-10-15 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions using low molecular weight amines |
US6550862B2 (en) * | 2001-06-14 | 2003-04-22 | Cosco Management, Inc. | Juvenile vehicle seat cup holder |
US6624203B1 (en) | 2001-11-08 | 2003-09-23 | Francis X. Smith | Nucleic acid bases used in ophthalmic solutions |
US6617291B1 (en) | 2001-11-08 | 2003-09-09 | Francis X. Smith | Ophthalmic and contact lens solutions |
-
2001
- 2001-11-08 DK DK01993467T patent/DK1339418T3/en active
- 2001-11-08 JP JP2002540744A patent/JP4084997B2/en not_active Expired - Fee Related
- 2001-11-08 PT PT01993467T patent/PT1339418E/en unknown
- 2001-11-08 CA CA2428985A patent/CA2428985C/en not_active Expired - Lifetime
- 2001-11-08 US US10/544,151 patent/US20060142169A1/en active Granted
- 2001-11-08 ES ES01993467T patent/ES2330617T3/en not_active Expired - Lifetime
- 2001-11-08 US US10/544,151 patent/US9492581B2/en not_active Expired - Fee Related
- 2001-11-08 WO PCT/US2001/046344 patent/WO2002038161A1/en active Application Filing
- 2001-11-08 AU AU2720602A patent/AU2720602A/en active Pending
- 2001-11-08 AT AT01993467T patent/ATE443749T1/en active
- 2001-11-08 AU AU2002227206A patent/AU2002227206B2/en not_active Ceased
- 2001-11-08 DE DE60140007T patent/DE60140007D1/en not_active Expired - Lifetime
- 2001-11-08 CN CNB018218172A patent/CN1245166C/en not_active Expired - Fee Related
- 2001-11-08 EP EP01993467A patent/EP1339418B1/en not_active Expired - Lifetime
-
2006
- 2006-09-07 AU AU2006207883A patent/AU2006207883B2/en not_active Ceased
-
2009
- 2009-10-14 CY CY20091101065T patent/CY1111043T1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6139646A (en) * | 1998-09-01 | 2000-10-31 | Alcon Laboratories, Inc. | Alkyl trypsin compositions and methods of use in contact lens cleaning and disinfecting systems |
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10531663B2 (en) | 2000-11-08 | 2020-01-14 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US9585394B2 (en) | 2000-11-08 | 2017-03-07 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
US9913474B2 (en) | 2000-11-08 | 2018-03-13 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US10064410B2 (en) | 2000-11-08 | 2018-09-04 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
US9308264B2 (en) | 2000-11-08 | 2016-04-12 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
US10244760B2 (en) | 2000-11-08 | 2019-04-02 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US10595532B2 (en) | 2000-11-08 | 2020-03-24 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
WO2002043482A2 (en) * | 2000-11-29 | 2002-06-06 | Novartis Ag | Aqueous disinfecting systems |
US7419944B2 (en) | 2000-11-29 | 2008-09-02 | Novartis Ag | Aqueous disinfecting systems |
WO2002043482A3 (en) * | 2000-11-29 | 2002-11-14 | Novartis Ag | Aqueous disinfecting systems |
US7550418B2 (en) | 2002-12-13 | 2009-06-23 | Novartis Ag | Lens care composition and method |
WO2005060953A1 (en) * | 2003-12-09 | 2005-07-07 | Alcon, Inc. | Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions |
WO2005089772A3 (en) * | 2004-03-12 | 2006-01-05 | Bausch & Lomb | Prevention of loss of tight cell junctions using carbohydrate-containing compositions |
WO2005089772A2 (en) * | 2004-03-12 | 2005-09-29 | Bausch & Lomb Incorporated | Prevention of loss of tight cell junctions using carbohydrate-containing compositions |
EP1642568A1 (en) * | 2004-08-03 | 2006-04-05 | Prontomed GmbH | Mouthwash |
US10213405B2 (en) | 2004-11-16 | 2019-02-26 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
US9668997B2 (en) | 2004-11-16 | 2017-06-06 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
EP2422765A1 (en) * | 2004-11-16 | 2012-02-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
US8569370B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
WO2006055454A3 (en) * | 2004-11-16 | 2006-08-03 | Allergan Inc | Ophthalmic compositions and methods for treating eyes |
WO2006055454A2 (en) * | 2004-11-16 | 2006-05-26 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
US8729125B2 (en) | 2004-11-16 | 2014-05-20 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
AU2012203398B2 (en) * | 2004-11-16 | 2015-01-15 | Allergan, Inc. | Opthalmic compositions and methods for treating eyes |
NO346214B1 (en) * | 2004-11-16 | 2022-04-25 | Allergan Inc | Ophthalmic compositions and procedures for the treatment of eyes |
US9254324B2 (en) | 2004-11-16 | 2016-02-09 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
WO2007027898A3 (en) * | 2005-08-31 | 2008-11-20 | Kimberly Clark Co | Antimicrobial composition |
WO2007027898A2 (en) * | 2005-08-31 | 2007-03-08 | Kimberly-Clark Worldwide, Inc. | Antimicrobial composition |
US11285216B2 (en) | 2005-10-06 | 2022-03-29 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
US11147878B2 (en) | 2005-10-06 | 2021-10-19 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
US11033625B2 (en) | 2005-10-06 | 2021-06-15 | Allergan, Inc. | Method for stabilizing a toxin |
US11446382B2 (en) | 2005-10-06 | 2022-09-20 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
US11524075B2 (en) | 2005-10-06 | 2022-12-13 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
US7858000B2 (en) | 2006-06-08 | 2010-12-28 | Novartis Ag | Method of making silicone hydrogel contact lenses |
WO2008077110A2 (en) * | 2006-12-19 | 2008-06-26 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
WO2008077110A3 (en) * | 2006-12-19 | 2008-09-25 | Fxs Ventures Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
WO2008086270A3 (en) * | 2007-01-05 | 2009-08-27 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing forms of vitamin b |
WO2008086270A2 (en) * | 2007-01-05 | 2008-07-17 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing forms of vitamin b |
US9162784B2 (en) | 2007-08-31 | 2015-10-20 | Novartis Ag | Contact lens packaging solutions |
US9348061B2 (en) | 2007-08-31 | 2016-05-24 | Novartis Ag | Contact lens products |
US8647658B2 (en) | 2007-08-31 | 2014-02-11 | Novartis Ag | Contact lens products |
US8689971B2 (en) | 2007-08-31 | 2014-04-08 | Novartis Ag | Contact lens packaging solutions |
US8957048B2 (en) | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
US10105386B2 (en) | 2011-10-06 | 2018-10-23 | Allergan, Inc. | Compositions for the treatment of dry eye |
US9314528B2 (en) | 2011-12-07 | 2016-04-19 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
US10888598B2 (en) | 2011-12-07 | 2021-01-12 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
US10279005B2 (en) | 2014-11-25 | 2019-05-07 | Allergan, Inc. | Stabilized omega-3 ophthalmic compositions |
US9829723B2 (en) | 2015-12-03 | 2017-11-28 | Novartis Ag | Contact lens packaging solutions |
US11202832B2 (en) | 2016-03-04 | 2021-12-21 | Johnson & Johnson Consumer Inc. | Preservative containing compositions |
US10632202B2 (en) | 2016-03-04 | 2020-04-28 | Johnson & Johnson Consumer Inc. | Preservative containing compositions |
WO2018109456A1 (en) * | 2016-12-12 | 2018-06-21 | Provita Eurotech Ltd | Antimicrobial compositions |
Also Published As
Publication number | Publication date |
---|---|
EP1339418B1 (en) | 2009-09-23 |
AU2006207883A1 (en) | 2006-09-28 |
DE60140007D1 (en) | 2009-11-05 |
CN1245166C (en) | 2006-03-15 |
US9492581B2 (en) | 2016-11-15 |
JP4084997B2 (en) | 2008-04-30 |
CY1111043T1 (en) | 2015-06-11 |
EP1339418A1 (en) | 2003-09-03 |
ATE443749T1 (en) | 2009-10-15 |
ES2330617T3 (en) | 2009-12-14 |
CA2428985A1 (en) | 2002-05-16 |
CA2428985C (en) | 2011-05-24 |
CN1486188A (en) | 2004-03-31 |
PT1339418E (en) | 2009-10-30 |
DK1339418T3 (en) | 2009-12-14 |
EP1339418A4 (en) | 2005-06-08 |
US20060142169A1 (en) | 2006-06-29 |
AU2006207883B2 (en) | 2009-08-06 |
AU2720602A (en) | 2002-05-21 |
AU2002227206B2 (en) | 2006-09-21 |
JP2004512904A (en) | 2004-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002227206B2 (en) | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers | |
AU2002227206A1 (en) | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers | |
US5593637A (en) | Method and composition for disinfecting contact lenses | |
US9492582B2 (en) | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers | |
EP1733014B1 (en) | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions | |
US20110212885A1 (en) | Ophthalmic and contact lens solutions containing peptides as preservative | |
US10531663B2 (en) | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers | |
EP2262521B1 (en) | Ophthalmic compositions comprising a dipeptide with a glycine moiety | |
US9132106B2 (en) | Synergistic ophthalmic compositions for disinfecting contact lenses | |
US20170127679A1 (en) | Ophthalmic contact lens solutions containing forms of vitamin b | |
IE920220A1 (en) | Method and composition for disinfecting contact lenses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002227206 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002540744 Country of ref document: JP Ref document number: 2428985 Country of ref document: CA Ref document number: 2001993467 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 734/KOLNP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018218172 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2001993467 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2006142169 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10544151 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10544151 Country of ref document: US |